Cortellis Drug Discovery Intelligence- Factsheet

CPHI Discover panel of industry experts discusses impact of COVID-19 on API manufacturing and trading as well as the controversial topic of reshoring production

Success in the highly competitive generics market requires speed and data-driven decisions to grow your business, defend your market share, stay ahead of competition and identify new markets, products and partners. Have confidence you’re making the most informed decisions using Cortellis Generics Intelligence™, the world’s only source of market performance, manufacturing, and patent data in a single, integrated solution.

Push your strategy forward with confidence:
Boost portfolio returns and improve patient outcomes by monitoring the competitive landscape, validating investments, and strategically prioritizing your portfolio.

Increase submission rates and avoid costly delays. Developing a drug is difficult. Going to market shouldn’t be. Trust a CMC solution, compiled by specialized industry experts, to prepare your dossiers accurately and swiftly.

Unlocking real-world insights Real World Data: Data solution for comprehensive and longitudinal understanding of market opportunities, clinical care, and outcomes in diverse therapeutic areas, including rare, complex and chronic diseases.